Roche, a Swiss global healthcare company, has been recognised by the Dow Jones Sustainability Indices (DJSI) as the group leader in sustainability within the pharmaceuticals, biotechnology and life sciences industry for the sixth consecutive year.

The DJSI has become the key reference for investors who integrate sustainability considerations into their portfolios.

The acknowledgement places Roche amongst the top 10 per cent of companies across all surveyed industries. Inclusion in the DJSI is based on an in-depth analysis of economic, social and environmental performance, assessing issues such as corporate governance, stakeholder engagement, risk management, supply chain standards and labour practices.

In this year’s assessment, Roche received the highest scores in several areas. This included how the company manages customer relationships, supply chain management, as well as addressing healthcare burden through the value of its products and services. The company also exceeded in nearly every area of employee engagement, including developing employees, respecting human rights and attracting and retaining good talents.

“It is very rewarding for us that Roche continues to be recognised as the most sustainable company within our peer group. Since the founding of Roche almost 120 years ago, sustainable, long-term thinking has guided our business practices”, said Severin Schwan, CEO of Roche. - TradeArabia News Service